<DOC>
	<DOCNO>NCT01556217</DOCNO>
	<brief_summary>The purpose study investigate concentration JNJ-39393406 achieve blood cerebrospinal fluid healthy adult volunteer follow administration single dose JNJ-39393406 .</brief_summary>
	<brief_title>A Pharmacokinetic Study Characterize JNJ-39393406 Cerebrospinal Fluid Healthy Volunteers</brief_title>
	<detailed_description>This single-centre , double-blind ( neither physician patient know name assign treatment ) , single dose study JNJ-39393406 placebo ( treatment identical appearance JNJ-39393406 contain active drug ) healthy adult volunteer . The study consist eligibility screen examination ( 21 2 day prior dose administration ) , double-blind treatment period , follow-up examination ( minimally 7 maximally 14 day dose administration ) . For volunteer , maximal study duration exceed 6 week . JNJ-39393406 placebo administer single 200-mg dose Day 1 liquid nanosuspension ( formulation use improve solubility drug ) 240 mL ( approximately 8 ounce 1 cup ) noncarbonated water 8:00 AM 10:30 AM standard breakfast consume ( follow fast [ eat food ] least 10 hour ) . Volunteers fast approximately 4 hour take JNJ-3939406 placebo lunch serve .</detailed_description>
	<criteria>Female volunteer must postmenopausal ( least 12 month ) Body mass index ( BMI ) 18 29.9 kg/m2 , inclusive Healthy basis physical examination , neurological examination , medical history , vital sign , 12lead ECG [ include QTcB interval duration &lt; 450 msec ] perform screen . Minor deviation ECG , consider clinical significance investigator , acceptable Healthy basis clinical laboratory test perform screen . If result serum chemistry panel [ include liver enzymes ] , hematology , urinalysis outside normal reference range , volunteer may include investigator judge abnormalities deviation normal clinically significant History liver renal insufficiency significant cardiac , vascular , pulmonary , gastrointestinal , endocrine , neurologic , hematologic , rheumatologic , psychiatric , metabolic disturbance Relevant history current neurological disease include history post dural puncture headache , low back pain scoliosis and/or major ( lumbar ) back surgery , spontaneous , prolong severe bleed unclear origin , epilepsy fit unexplained blackout History family history abnormal bleeding blood clot anemia</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>JNJ-39393406-aaa</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Central brain penetrance</keyword>
	<keyword>Cerebral spinal fluid</keyword>
</DOC>